NRXP insider filings
NRX Pharmaceuticals, Inc. — 11 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-02-17. Screen NRXP transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for NRXP between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.
Recent insider filings — NRX Pharmaceuticals, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-17 | 4 | Casper Joseph Michael — Chief Operating Officer | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-09-10 | 4 | McBride Dennis — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-09-10 | 4 | Flynn Patrick John — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-09-10 | 4 | Hurvitz Chaim — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-09-10 | 4 | Javitt Jonathan C — Chairman and Chief Scientist, Director, 10% owner | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | ABRAMS MICHAEL S — Chief Financial Officer | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-12-18 | 4 | Javitt Jonathan C — Chairman and Chief Scientist, Director, 10% owner | Purchase (P): 40,000 @ $1.17 | EDGAR |
| 2023-09-11 | 4 | Gorovitz Aaron — Director | Purchase (P): 35,000 @ $0.32 | EDGAR |
| 2023-09-11 | 4 | Hurvitz Chaim — Director | Purchase (P): 70,000 @ $0.29 | EDGAR |
| 2023-08-24 | 4 | Javitt Jonathan C — Chief Scientist, Director, 10% owner | Purchase (P): 100,000 @ $0.33 | EDGAR |
| 2023-08-23 | 4 | Javitt Jonathan C — Chief Scientist, Director, 10% owner | Purchase (P): 200,000 @ $0.32 | EDGAR |
Recent 8-K events — NRX Pharmaceuticals, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-10-05 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-16 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-14 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-17 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-07 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
| 2026-07-22 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-06-04 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-02 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-24 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-17 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=NRXP returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →